Search results for tenascin C

Anti-Tenascin C antibody [DB7], Abcam, AB86182

ab86182 is derived from the hybridoma produced by fusion between myeloma cells and Balb/c spleen cells.

Anti-Tenascin C antibody [EB2], Abcam, AB88280

ab88280 is derived from the hybridoma produced by fusion between myeloma cells and Balb/c spleen cells.

Anti-Tenascin C antibody [EPR4219], Abcam, AB108930

Product Specifications Anti-Tenascin C antibody [EPR4219] (ab108930) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-Fr, IHC-P, WB in human, mouse, rat samples. Anti-Tenascin C antibody [EPR4219] (ab108930) specifically detects Tenascin C (UniProt ID: P24821; Molecular weight: 239kDa) and is sold in 100 µL and 1 mL selling sizes. Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-Tenascin C antibody [EPR4219] (ab108930) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Tenascin C antibody [EPR4219] (ab108930) has been confirmed by testing in knockout samples. Anti-Tenascin C antibody [EPR4219] (ab108930) has been cited over 95 times in peer reviewed journals and is trusted by the scientific community. Anti-Tenascin C antibody [EPR4219] (ab108930) has 10 independent reviews from customers. Related Products Antibody clone EPR4219 is also available pre-conjugated to a variety of labels for your convenience - HRP, PE, APC, Alexa Fluor® 488, Alexa Fluor® 594, Alexa Fluor® 555, Alexa Fluor® 647, Alexa Fluor® 750 ( ab196918 , ab317894 , ab317931 , ab317971 , ab318012 , ab318054 , ab318096 , ab320917 ). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Tenascin C antibody [SPM319], Abcam, AB233882

Anti-Tenascin C antibody [T2H5], Abcam, AB3970

Tenascin is a high molecular weight, multifunctional, hexameric extracellular matrix glycoprotein expressed in association with mesenchymal epithelial interactions during development and in the neovasculature and stroma of undifferentiated tumors. It has been described under a variety of names: cytotactin, hexabrachion protein, J1, myotendinous antigen (MI) and glioma mesenchymal extracellular matrix (GMEM). The tenascin molecule is a disulfide-linked hexamer. The expression of tenascin is associated with development and growth, both normal and pathological, whereas the distribution in normal adult tissue is restricted.

Tenascin C antibody [MTn-12], Genetex, GTX26346

Human Tenascin-C (TNC) ELISA Kit, Abbkine, KTE62317

• Do not mix components from different kit lots or use reagents beyond the kit expiration date.• Allow all reagents to warm to room temperature for at least 30 minutes before opening.• Pre-rinse the pipet tip with reagent, use fresh pipet tips for each sample, standard and reagent to avoid contamination. • Unused wells must be kept desiccated at 4 °C in the sealed bag provided.• Mix Thoroughly is very important for the result. It is recommended using low frequency oscillator or slight hand shaking every 10 minutes.• It is recommended that all samples and standards be assayed in duplicate or triplicate.

PE Anti-Tenascin C antibody [EPR4219], Abcam, AB317894

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

APC Anti-Tenascin C antibody [EPR4219], Abcam, AB317931

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Anti-Tenascin C antibody - C-terminal, Abcam, AB226916